Decision of the EEA Joint Committee No 49/2023 of 17 March 2023 amending Annex II... (22023D2338)
EU - Internationale Abkommen
2023/2338
26.10.2023

DECISION OF THE EEA JOINT COMMITTEE No 49/2023

of 17 March 2023

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/2338]

THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
(1) Commission Implementing Regulation (EU) 2022/944 of 17 June 2022 laying down rules for the application of Regulation (EU) 2017/746 of the European Parliament and of the Council as regards the tasks of and criteria for European Union reference laboratories in the field of in vitro diagnostic medical devices  ( 1 ) is to be incorporated into the EEA Agreement.
(2) Commission Implementing Regulation (EU) 2022/945 of 17 June 2022 laying down rules for the application of Regulation (EU) 2017/746 of the European Parliament and the Council with regard to fees that may be levied by EU reference laboratories in the field of in vitro diagnostic medical devices  ( 2 ) is to be incorporated into the EEA Agreement.
(3) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:

Article 1

The following points are inserted after point 12a (Commission Implementing Regulation (EU) 2022/1107) of Chapter XXX of Annex II to the EEA Agreement:
‘12b.
32022 R 0944 : Commission Implementing Regulation (EU) 2022/944 of 17 June 2022 laying down rules for the application of Regulation (EU) 2017/746 of the European Parliament and of the Council as regards the tasks of and criteria for European Union reference laboratories in the field of in vitro diagnostic medical devices ( OJ L 164, 20.6.2022, p. 7 ).
12c.
32022 R 0945 : Commission Implementing Regulation (EU) 2022/945 of 17 June 2022 laying down rules for the application of Regulation (EU) 2017/746 of the European Parliament and the Council with regard to fees that may be levied by EU reference laboratories in the field of in vitro diagnostic medical devices ( OJ L 164, 20.6.2022, p. 20 ).’

Article 2

The texts of Implementing Regulations (EU) 2022/944 and (EU) 2022/945 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 18 March 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made  ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .
Done at Brussels, 17 March 2023.
For the EEA Joint Committee
The President
Nicolas VON LINGEN
( 1 )    OJ L 164, 20.6.2022, p. 7 .
( 2 )    OJ L 164, 20.6.2022, p. 20 .
( *1 )   No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2023/2338/oj
ISSN 1977-0677 (electronic edition)
Markierungen
Leseansicht